The TRPM7 inhibitor 2-aminoethyl diphenylborinate (2-APB [157]) attenuates MDA-MB-231, AU565, and T47D cell proliferation, increasing S phase and decreasing G0/G1 phase in the breast cancer cell cycle [158]. The gene discussed is TRPM7; the disease is breast carcinoma.